Serious Bacterial Infection
4 clinical trials · Condition
◉ Watch Serious Bacterial Infection
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria (NCT03580044) | Pfizer | 2020-12-25 |
Track Serious Bacterial Infection automatically
Every clearance here is in the API, with alerts when new ones post.